Kenneth Kalunian
- Rheumatology top 0.05%
- Systemic Lupus Erythematosus Research 108
- Rheumatoid Arthritis Research and Therapies 27
- Osteoarthritis Treatment and Mechanisms 15
- Immunology top 0.2%
- T-cell and B-cell Immunology 31
- Atherosclerosis and Cardiovascular Diseases 13
-
- Monoclonal and Polyclonal Antibodies Research 57
- Hematology top 1%
- Nephrology top 2%
-
- Chronic Lymphocytic Leukemia Research 16
-
- Cytokine Signaling Pathways and Interactions 14
- Co-authors
- Joan T. MerrillRichard FurieMichelle PetriDaniel J. WallaceMunther A. KhamashtaDavid IsenbergVictoria P. WerthLiangwei Wang
- Journals
- Annals of the Rheumatic Diseases (34 papers)Lupus Science & Medicine (13 papers)Lara D. Veeken (9 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Kenneth Kalunian
143 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Rheumatology 6.5k
- Immunology 4.5k
- Radiology, Nuclear Medicine and Imaging 2.4k
- Hematology 683
- Nephrology 388
Countries citing papers authored by Kenneth Kalunian
This map shows the geographic impact of Kenneth Kalunian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Kalunian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Kalunian more than expected).
Fields of papers citing papers by Kenneth Kalunian
This network shows the impact of papers produced by Kenneth Kalunian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Kalunian. The network helps show where Kenneth Kalunian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenneth Kalunian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 2 | |
| 8 | Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)breakdown → | 2023 | 89 |
| 9 | 2022 | 26 | |
| 10 | 2022 | 12 | |
| 11 | 2020 | 0 | |
| 12 | 2020 | 1 | |
| 13 | 2013 | 200 | |
| 14 | 2013 | 250 | |
| 15 | 2012 | 62 | |
| 16 | 2011 | 1 | |
| 17 | 2000 | 1 | |
| 18 | 1997 | 202 | |
| 19 | Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. | 1992 | 103 |
| 20 | 1988 | 3 |
About Kenneth Kalunian
Kenneth Kalunian is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 156 papers that have together received 8.2k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (108 papers), Monoclonal and Polyclonal Antibodies Research (57 papers), T-cell and B-cell Immunology (31 papers), Rheumatoid Arthritis Research and Therapies (27 papers), Chronic Lymphocytic Leukemia Research (16 papers), Osteoarthritis Treatment and Mechanisms (15 papers), Cytokine Signaling Pathways and Interactions (14 papers) and Atherosclerosis and Cardiovascular Diseases (13 papers). The work is most often cited by research in Rheumatology (6.5k citations), Immunology (4.5k citations) and Radiology, Nuclear Medicine and Imaging (2.4k citations). Kenneth Kalunian has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Joan T. Merrill, Richard Furie, Michelle Petri, Daniel J. Wallace, Munther A. Khamashta, David Isenberg, Victoria P. Werth, Liangwei Wang, Jörn Drappa and Caroline Gordon. Their work appears in journals such as Annals of the Rheumatic Diseases, Lupus Science & Medicine, Lara D. Veeken, Arthritis & Rheumatology and Osteoarthritis and Cartilage.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.